Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 3Other 2Thoracic 1Other solid neoplasm 1Head & Neck 1Gynecologic 1

Conditions

Sexual Dysfunctions, Psychological 1Obesity 1Metabolic Syndrome 1Inflammation 1Dyslipidemias 1Breast Neoplasms 1

Interventions

Tirzepatide 9Methods 8Educational Status 8Exercise 6Early Intervention, Educational 6Interviews as Topic 5Counseling 5Surveys and Questionnaires 4semaglutide 3Standard of Care 3Specimen Handling 3Resistance Training 3Radiotherapy 3Nutrition Assessment 3naldemedine 2Transcutaneous Electric Nerve Stimulation 2Tablets 2Progestins 2Mouthwashes 2Mindfulness 2Metformin 2Megestrol Acetate 2Letrozole 2Health Promotion 2Exercise Test 2Echocardiography 2Drug Therapy 2Diet Therapy 2Bupropion 2mirabegron 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Bupropion × Other × 1 year × Clear all
NCT07596212 2026-05-19

BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder

University of Illinois at Chicago

Phase 1/2 Not yet recruiting
100 enrolled
BreastOther

Breast Neoplasms, Sexual Dysfunctions, Psychological

NCT05756764 2025-09-09

Anti-obesity Pharmacotherapy and Inflammation

Louisiana State University Health Sciences Center in New Orleans

Active not recruiting
30 enrolled
Other

Inflammation, Obesity, Metabolic Syndrome, Dyslipidemias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡